Robert E. Reiter, MD, MBA

Robert E. Reiter, MD, MBA

Geffen School of Medicine at UCLA

Los Angeles, CA

Dr. Reiter is the Bing Professor of Urology and Molecular Biology and Director of the Prostate Cancer Treatment and Research Program at the David Geffen School of Medicine at UCLA. He is currently the Principal Investigator of UCLA’s SPORE (Specialized Program in Research Excellence) program, a 12 million dollar research grant from the National Cancer Institute to develop new diagnostic and treatment options for men with prostate cancer. Dr. Reiter's clinical interests include robotic surgical management of prostate cancer, as well as the use of both MRI and molecular imaging tools to manage this disease. His research is focused on the development of novel antibodies for both treatment and imaging of prostate cancer, as well as on the role of epithelial to mesenchymal transition in castration and treatment resistance. Dr. Reiter completed his undergraduate studies at Yale University and medicine at Stanford University Medical School.

Articles by Robert E. Reiter, MD, MBA

Join the GRU Community

- Why Join? -